{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T18:18:44Z","timestamp":1794507524893,"version":"4.9.1"},"reference-count":50,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T00:00:00Z","timestamp":1713744000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA274439 , R01CA269811 , R21EB028429"],"award-info":[{"award-number":["R01CA274439 , R01CA269811 , R21EB028429"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Pancreatic cancer is a significant cause of cancer-related mortality and often presents with limited treatment options. Pancreatic tumors are also notorious for their immunosuppressive microenvironment. Irreversible electroporation (IRE) is a non-thermal tumor ablation modality that employs high-voltage microsecond pulses to transiently permeabilize cell membranes, ultimately inducing cell death. However, the understanding of IRE\u2019s impact beyond the initiation of focal cell death in tumor tissue remains limited. In this study, we demonstrate that IRE triggers a unique mix of cell death pathways and orchestrates a shift in the local tumor microenvironment driven, in part, by reducing the myeloid-derived suppressor cell (MDSC) and regulatory T cell populations and increasing cytotoxic T lymphocytes and neutrophils. We further show that IRE drives induce cell cycle arrest at the G0\/G1 phase <jats:italic>in vitro<\/jats:italic> and promote inflammatory cell death pathways consistent with pyroptosis and programmed necrosis <jats:italic>in vivo<\/jats:italic>. IRE-treated mice exhibited a substantial extension in progression-free survival. However, within a span of 14 days, the tumor immune cell populations reverted to their pre-treatment composition, which resulted in an attenuation of the systemic immune response targeting contralateral tumors and ultimately resulting in tumor regrowth. Mechanistically, we show that IRE augments IFN-\u00a0\u03b3 signaling, resulting in the up-regulation of the PD-L1 checkpoint in pancreatic cancer cells. Together, these findings shed light on potential mechanisms of tumor regrowth following IRE treatment and offer insights into co-therapeutic targets to improve treatment strategies.<\/jats:p>","DOI":"10.3389\/fimmu.2024.1352821","type":"journal-article","created":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T05:09:50Z","timestamp":1713762590000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":28,"title":["Irreversible electroporation promotes a pro-inflammatory tumor microenvironment and anti-tumor immunity in a mouse pancreatic cancer model"],"prefix":"10.3389","volume":"15","author":[{"given":"Khan Mohammad","family":"Imran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca M.","family":"Brock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Beitel-White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manali","family":"Powar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"Orr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth N.","family":"Aycock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nastaran","family":"Alinezhadbalalami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaid S.","family":"Salameh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paige","family":"Eversole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Tintera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Markov Madanick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alissa","family":"Hendricks-Wenger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheryl","family":"Coutermarsh-Ott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael V.","family":"Davalos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irving C.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,4,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"3157","DOI":"10.3748\/wjg.v21.i11.3157","article-title":"Update on the management of pancreatic cancer: surgery is not enough","volume":"21","author":"Ansari","year":"2015","journal-title":"World J gastroenterol: WJG"},{"key":"B2","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/nrgastro.2010.188","article-title":"Pancreatic cancer: understanding and overcoming chemoresistance","volume":"8","author":"Wang","year":"2011","journal-title":"Nat Rev Gastroenterol hepatol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1404198","article-title":"Pancreatic adenocarcinoma","volume":"371","author":"Ryan","year":"2014","journal-title":"N Engl J Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3390\/cancers10020039","article-title":"Precision immuno-oncology: prospects of individualized immunotherapy for pancreatic cancer","volume":"10","author":"Zhang","year":"2018","journal-title":"Cancers"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-199804000-00018","article-title":"Radiofrequency ablation of porcine liver in vivo: effects of blood flow and treatment time on lesion size","volume":"227","author":"Patterson","year":"1998","journal-title":"Ann Surg"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2020192190","article-title":"High-voltage electrical pulses in oncology: irreversible electroporation, electrochemotherapy, gene electrotransfer, electrofusion, and electroimmunotherapy","volume":"295","author":"Geboers","year":"2020","journal-title":"Radiology"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-019-07261-7","article-title":"Systematic review of surgical and percutaneous irreversible electroporation in the treatment of locally advanced pancreatic cancer","volume":"26","author":"Moris","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2019.05.036","article-title":"High-frequency irreversible electroporation is an effective tumor ablation strategy that induces immunologic cell death and promotes systemic anti-tumor immunity","volume":"44","author":"Ringel-Scaia","year":"2019","journal-title":"EBioMedicine"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1652532","DOI":"10.1080\/2162402X.2019.1652532","article-title":"Irreversible electroporation of locally advanced pancreatic cancer transiently alleviates immune suppression and creates a window for antitumor T cell activation","volume":"8","author":"Scheffer","year":"2019","journal-title":"Oncoimmunology"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1007\/s10439-005-8981-8","article-title":"Tissue ablation with irreversible electroporation","volume":"33","author":"Davalos","year":"2005","journal-title":"Ann Biomed Eng"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/S0302-4598(96)05062-3","article-title":"Theory of electroporation: a review","volume":"41","author":"Weaver","year":"1996","journal-title":"Bioelectrochem Bioenerg"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijsu.2015.06.049","article-title":"Percutaneous CT-guided irreversible electroporation followed by chemotherapy as a novel neoadjuvant protocol in locally advanced pancreatic cancer: Our preliminary experience","volume":"21","author":"Belfiore","year":"2015","journal-title":"Int J Surg"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000001441","article-title":"Treatment of 200 locally advanced (stage III) pancreatic adenocarcinoma patients with irreversible electroporation: safety and efficacy","volume":"262","author":"Martin","year":"2015","journal-title":"Ann Surg"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1002\/jso.24288","article-title":"Irreversible electroporation enhances delivery of gemcitabine to pancreatic adenocarcinoma","volume":"114","author":"Bhutiani","year":"2016","journal-title":"J Surg Oncol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"275","DOI":"10.21037\/jgo","article-title":"Percutaneous irreversible electroporation with systemic treatment for locally advanced pancreatic adenocarcinoma","volume":"9","author":"Leen","year":"2018","journal-title":"J gastrointestinal Oncol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2012.04.025","article-title":"Tumor-derived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and T cell immunity in pancreatic cancer","volume":"21","author":"Bayne","year":"2012","journal-title":"Cancer Cell"},{"key":"B17","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.bioelechem.2016.09.003","article-title":"Irreversible electroporation inhibits pro-cancer inflammatory signaling in triple negative breast cancer cells","volume":"113","author":"Goswami","year":"2017","journal-title":"Bioelectrochemistry"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-021-00796-4","article-title":"Distinct roles but cooperative effect of TLR3\/9 agonists and PD-1 blockade in converting the immunotolerant microenvironment of irreversible electroporation-ablated tumors","volume":"18","author":"Babikr","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.853779","article-title":"Exploration of novel pathways underlying irreversible electroporation induced anti-tumor immunity in pancreatic cancer","volume":"12","author":"Imran","year":"2022","journal-title":"Front Oncol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.01235","article-title":"Starting a fire without flame: The induction of cell death and inflammation in electroporation-based tumor ablation strategies","volume":"10","author":"Brock","year":"2020","journal-title":"Front Oncol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-021-08176-x","article-title":"Immunological effect of irreversible electroporation on hepatocellular carcinoma","volume":"21","author":"Guo","year":"2021","journal-title":"BMC cancer"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-19-0101","article-title":"Irreversible electroporation combined with checkpoint blockade and TLR7 stimulation induces antitumor immunity in a murine pancreatic cancer model","volume":"7","author":"Narayanan","year":"2019","journal-title":"Cancer Immunol Res"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-018-07144-3","article-title":"Evaluating the regulatory immunomodulation effect of irreversible electroporation (IRE) in pancreatic adenocarcinoma","volume":"26","author":"Pandit","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1080\/02656736.2018.1539253","article-title":"Engineering T cell response to cancer antigens by choice of focal therapeutic conditions","volume":"36","author":"Shao","year":"2019","journal-title":"Int J Hyperthermia"},{"key":"B25","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1038\/s41467-019-08782-1","article-title":"Irreversible electroporation reverses resistance to immune checkpoint blockade in pancreatic cancer","volume":"10","author":"Zhao","year":"2019","journal-title":"Nat Commun"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1089\/bioe.2019.0029","article-title":"Irreversible electroporation: background, theory, and review of recent developments in clinical oncology","volume":"1","author":"Aycock","year":"2019","journal-title":"Bioelectricity"},{"key":"B27","doi-asserted-by":"publisher","first-page":"107871","DOI":"10.1016\/j.bioelechem.2021.107871","article-title":"Cell death due to electroporation\u2013a review","volume":"141","author":"Napotnik","year":"2021","journal-title":"Bioelectrochemistry"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1007\/s002329900522","article-title":"Electric field pulses can induce apoptosis","volume":"169","author":"Hofmann","year":"1999","journal-title":"J membrane Biol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1007\/s10439-020-02462-8","article-title":"Dynamics of cell death after conventional IRE and H-FIRE treatments","volume":"48","author":"Mercadal","year":"2020","journal-title":"Ann Biomed Eng"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1023\/A:1026497306006","article-title":"Apoptotic and necrotic cell death are both induced by electroporation in HL60 human promyeloid leukaemia cells","volume":"2","author":"Pinero","year":"1997","journal-title":"Apoptosis"},{"key":"B31","doi-asserted-by":"publisher","first-page":"317","DOI":"10.2478\/raon-2020-0047","article-title":"Analysis of damage-associated molecular pattern molecules due to electroporation of cells in vitro","volume":"54","author":"Polajzer","year":"2020","journal-title":"Radiol Oncol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-55113-5_17","article-title":"From local to systemic treatment: leveraging antitumor immunity following irreversible electroporation","author":"Stam","year":"2018","journal-title":"Irreversible Electroporation Clin Pract"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1155831","article-title":"NLRX1 functions as a tumor suppressor in Pan02 pancreatic cancer cells","volume":"13","author":"Nagai-Singer","year":"2023","journal-title":"Front Oncol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"11142","DOI":"10.3748\/wjg.v20.i32.11142","article-title":"Therapeutic options for the management of pancreatic cancer","volume":"20","author":"Rossi","year":"2014","journal-title":"World J Gastroenterol: WJG"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2017.04.031","article-title":"Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression","volume":"19","author":"Garcia-Diaz","year":"2017","journal-title":"Cell Rep"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1875638","DOI":"10.1080\/2162402X.2021.1875638","article-title":"Irreversible electroporation ablation overcomes tumor-associated immunosuppression to improve the efficacy of DC vaccination in a mice model of pancreatic cancer","volume":"10","author":"Yang","year":"2021","journal-title":"Oncoimmunology"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.12120609","article-title":"Irreversible electroporation ablation: is all the damage nonthermal","volume":"266","author":"Faroja","year":"2013","journal-title":"Radiology"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2008.08.060","article-title":"Phagocytic clearance of electric field induced A\u2019poptosis-mimetic\u2019cells","volume":"376","author":"Tekle","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1002\/(ISSN)1097-0142","article-title":"Electrochemotherapy, a new antitumor treatment","volume":"72","author":"Belehradek","year":"1993","journal-title":"First Clin phase I-II trial Cancer"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1002\/(ISSN)1097-0142","article-title":"Phase I\/II trial for the treatment of cutaneous and subcutaneous tumors using electrochemotherapy","volume":"77","author":"Heller","year":"1996","journal-title":"Cancer: Interdiscip Int J Am Cancer Society"},{"key":"B41","doi-asserted-by":"publisher","first-page":"925","DOI":"10.3390\/vaccines11050925","article-title":"Effects of electrochemotherapy on immunologically important modifications in tumor cells","volume":"11","author":"Kesar","year":"2023","journal-title":"Vaccines"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1189960","article-title":"The effectiveness of calcium electroporation combined with gene electrotransfer of a plasmid encoding IL-12 is tumor type-dependent","volume":"14","author":"Lisec","year":"2023","journal-title":"Front Immunol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioelechem.2017.09.009","article-title":"Comparable effectiveness and immunomodulatory actions of oxaliplatin and cisplatin in electrochemotherapy of murine melanoma","volume":"119","author":"Ursic","year":"2018","journal-title":"Bioelectrochemistry"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1533033819876899","DOI":"10.1177\/1533033819876899","article-title":"Time-dependent impact of irreversible electroporation on pathology and ablation size in the porcine liver: a 24-hour experimental study","volume":"18","author":"Vogel","year":"2019","journal-title":"Technol Cancer Res Treat"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1011923","article-title":"FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer","volume":"364","author":"Conroy","year":"2011","journal-title":"N Engl J Med"},{"key":"B46","article-title":"Synergy between chemotherapy and immunotherapy in the treatment of established murine solid tumors","volume":"63","author":"Nowak","year":"2003","journal-title":"Cancer Res"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2013.12.022","article-title":"Gemcitabine-treated pancreatic cancer cell medium induces the specific CTL antitumor activity by stimulating the maturation of dendritic cells","volume":"19","author":"Pei","year":"2014","journal-title":"Int immunopharmacol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2012.12.042","article-title":"Role of immune cells and immune-based therapies in pancreatitis and pancreatic ductal adenocarcinoma","volume":"144","author":"Zheng","year":"2013","journal-title":"Gastroenterol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"200ra116","DOI":"10.1126\/scitranslmed.3006504","article-title":"Up-regulation of PD-L1, IDO, and Tregs in the melanoma tumor microenvironment is driven by CD8+ T cells","volume":"5","author":"Spranger","year":"2013","journal-title":"Sci Trans Med"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2018.06.011","article-title":"Mapping genes for drug chronotherapy","volume":"23","author":"Wei","year":"2018","journal-title":"Drug Discov Today"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1352821\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T05:09:57Z","timestamp":1713762597000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1352821\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,22]]},"references-count":50,"alternative-id":["10.3389\/fimmu.2024.1352821"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2024.1352821","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fimmu.2024.1352821.s001","asserted-by":"subject"}]},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,22]]},"article-number":"1352821"}}